Key findings
- • The median healthcare AI market grows at 18.2% a year from 2025 to 2035.
- • AI medical scribing grows from US$1.4 Bn to US$12.8 Bn (24.8% CAGR) - documentation is the fastest route to adoption.
- • AI in drug development is estimated at US$8.0 Bn in 2025, reaching US$41.9 Bn by 2035.
- • Clinical AI agents are already a US$1.7 Bn market.
Healthcare AI markets, 2025 vs 2035
| Market | 2025 (US$) | 2035 (US$) | CAGR 2025-2035 |
|---|---|---|---|
| Artificial Intelligence (AI) in Medical Diagnostics | $5.4 Bn | $27.3 Bn | 17.6% |
| AI Drug Development | $8.0 Bn | $41.9 Bn | 18.0% |
| AI Smart Hospital Platform | $6.5 Bn | $31.2 Bn | 17.0% |
| AI Clinical Documentation Platform | $1.9 Bn | $14.6 Bn | 22.6% |
| AI Medical Scribing | $1.4 Bn | $12.8 Bn | 24.8% |
| Clinical AI Agents | $1.7 Bn | $16.6 Bn | 25.6% |
| AI Clinical Trial Analytics | $1.0 Bn | $7.0 Bn | 21.5% |
| AI Protein Design | $900.0 Mn | $6.6 Bn | 22.0% |
| AI Genomic Diagnostics | $800.1 Mn | $6.9 Bn | 24.0% |
| AI Pathology | $600.0 Mn | $4.0 Bn | 20.9% |
| AI Hospital Digital Twin | $1.2 Bn | $8.8 Bn | 22.0% |
| AI Respiratory Diagnostics | $300.1 Mn | $4.1 Bn | 29.9% |
Source: Market-Reports.com estimates. Base year 2025, forecast to 2035.
Paperwork first
The quickest healthcare AI wins are administrative. Scribing and clinical documentation tools save clinician time without changing clinical decisions, which keeps regulatory hurdles low and the return easy to measure. That is why they sit among the fastest-growing healthcare AI markets.
Diagnostics next
Image- and signal-based diagnostics - pathology, respiratory and genomic analysis - follow, where AI assists specialists with large volumes of data. Adoption depends on validation and reimbursement, so growth is steady rather than explosive, but the markets are large and broad.
Discovery is the long game
AI in drug development and protein design aims at the most valuable problem in the industry: shortening the path from target to medicine. These markets are smaller than their ambitions today; their value will be set by how many AI-designed candidates make it through trials.
About the data
All figures are Market-Reports.com estimates of global market revenue in US dollars, with 2025 as the base year and forecasts to 2035; growth rates are compound annual growth rates (CAGR) for 2025-2035. They come from our catalogue of more than 4,600 market reports across 19 industries, in which every market is sized on its own definition. Markets overlap - an AI server is also part of AI infrastructure - so the figures in this study must not be added together. Medians are calculated across all reports whose market name matches the theme, as published in October 2026.
Use this data
Journalists, analysts and bloggers may quote these figures and reproduce the table, with credit to Market-Reports.com and a link to this page:
Source: Market-Reports.com, "AI in Healthcare: From Medical Scribes to Protein Design, 12 Markets Sized" - https://www.market-reports.com/insights/ai-in-healthcare-market-sizes-2035
Need a figure for a different market or region? Email contact@market-reports.com.
Key takeaways
- • Documentation tools are the fastest route to healthcare AI adoption.
- • Diagnostics markets are large and grow steadily with validation.
- • Drug discovery AI is the long-term prize.